| pubmed-article:15147247 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15147247 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
| pubmed-article:15147247 | lifeskim:mentions | umls-concept:C0754647 | lld:lifeskim |
| pubmed-article:15147247 | lifeskim:mentions | umls-concept:C0332167 | lld:lifeskim |
| pubmed-article:15147247 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15147247 | pubmed:dateCreated | 2004-5-18 | lld:pubmed |
| pubmed-article:15147247 | pubmed:abstractText | To investigate the cardiovascular effects of frovatriptan 2.5 mg during a migraine attack in patients with, or at high risk of, coronary artery disease. | lld:pubmed |
| pubmed-article:15147247 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15147247 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147247 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15147247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147247 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147247 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15147247 | pubmed:month | May | lld:pubmed |
| pubmed-article:15147247 | pubmed:issn | 0017-8748 | lld:pubmed |
| pubmed-article:15147247 | pubmed:author | pubmed-author:KeywoodCharlo... | lld:pubmed |
| pubmed-article:15147247 | pubmed:author | pubmed-author:ElkindArthur... | lld:pubmed |
| pubmed-article:15147247 | pubmed:author | pubmed-author:SatinLawrence... | lld:pubmed |
| pubmed-article:15147247 | pubmed:author | pubmed-author:NilaAliceA | lld:pubmed |
| pubmed-article:15147247 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15147247 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:15147247 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15147247 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15147247 | pubmed:pagination | 403-10 | lld:pubmed |
| pubmed-article:15147247 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:meshHeading | pubmed-meshheading:15147247... | lld:pubmed |
| pubmed-article:15147247 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15147247 | pubmed:articleTitle | Frovatriptan use in migraineurs with or at high risk of coronary artery disease. | lld:pubmed |
| pubmed-article:15147247 | pubmed:affiliation | Elkind Headache Center, Mount Vernon, NY 10550, USA. | lld:pubmed |
| pubmed-article:15147247 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15147247 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15147247 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15147247 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147247 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147247 | lld:pubmed |
